Skip to content

Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients

Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03314675
Acronym
BIO|PULSE
Enrollment
16
Registered
2017-10-19
Start date
2018-02-26
Completion date
2018-07-06
Last updated
2018-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

CRT-D, LV Latency

Brief summary

The study is designed to collect data on LV latency in CRT-D patients by the CRT-D and compare measurements to 12-lead ECG data

Interventions

DEVICEBIOTRONIK CRT-D

Pre-specified follow-up and measurements

Sponsors

Biotronik SE & Co. KG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has been implanted with a CRT-D device by BIOTRONIK at least 4 weeks before enrollment date * Patient successfully implanted with a left ventricular lead * High likelihood of LV latency ≥ 40 ms * LV lead in lateral or postero-lateral position in the coronary venous system * Patient is able to understand the nature of the clinical investigation * Patient is willing to undergo the required measurements at the investigation site * Patient provides written informed consent * Age ≥ 18 years

Exclusion criteria

* Patients with irregular ventricular rhythm due to atrial tachycardia * Pregnant or breast-feeding women * Participation in an interventional clinical investigation

Design outcomes

Primary

MeasureTime frame
Rate of patients with LV latency >/= 40ms (stimulus to QRS onset) with respect to the total number of screened patients1 day

Secondary

MeasureTime frame
Device-base measured LV latency in the LV IEGM channel and Far Field channel1 day
12-lead ECG-measured LV latency in the channel with earliest QRS onset1 day
Device-based measured latency intervals (stimulus to electrogram peak and end) in the LV IEGM channel and the Far Field channel1 day
12-lead ECG-measured latency intervals1 day

Countries

Czechia, Germany, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026